Investec Sets ₹1,730 Target for Medanta; Bed Capacity Up 47%
Investec gives Buy rating to Global Health with Rs 1,730 target. Medanta expands bed capacity by 47%, occupancy continues to improve. Source: NDTV Profit
Stock news timeline · MEDANTA
News timeline · Last 30 days
23 Aug 2026 – 21 Sep 2026 · Times in IST
Showing 13 of 13 updates · Newest first
Change the keyword or sentiment above, then click Apply.
Investec gives Buy rating to Global Health with Rs 1,730 target. Medanta expands bed capacity by 47%, occupancy continues to improve. Source: NDTV Profit
Global Health posts Q2 operating profit of ₹197.2 Cr, income ₹1,099.22 Cr. Stock prices range ₹1,404-₹1,437; Healthcare Facilities sector focus. Source: livemint.com
Global Health disclosed AGM proceedings held on Sep 16, 2026. Investor meet intimation shared under SEBI LODR Regulation 30. Source: Moneycontrol
Investec initiates Buy on Global Health with ₹1,730 target price, citing scaling, ARPOB growth, and bed capacity doubling potential. Revenue/EBITDA CAGR forecasted at ~16%/23% over FY26–29; major bed additions expected post-FY29E. Source: Livesquawk
Global Health Ltd plans an investor/analyst meeting with USS Investment on Sep 23, 2026. The meeting in Gurugram will be in-person with no sensitive info shared. Source: BSE
Global Health Ltd announces analyst/investor meet on Sep 15, 2026, in Noida. Meeting, organized by Jefferies, will be in person with no UPSI disclosure. Source: BSE
Global Health Ltd (Medanta) informs about investor/analyst meetings on Sept 10 & 14, 2026. Meetings with Polar Capital & Chikara Investments will be held in Gurugram, in person. Source: BSE
Global Health Ltd to meet investors/analysts on Aug 31, 2026, in Noida. Meeting, organized by Prabhudas Lilladher, will share no unpublished price-sensitive info. Source: BSE